Effect of hyaluronic acid amide derivative on equine synovial fluid viscoelasticity

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 3, 2010, Pages 1162-1170

  Borzacchiello, A ^a   Mayol, L ^b   Schiavinato, A ^c   Ambrosio, L ^a  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Fidia Advanced Biopolymers   (Italy)

Author keywords

Hyaluronic acid derivatives; Rheological properties; Synovial fluid; Viscoelasticity; Viscosupplementation therapy

Indexed keywords

AMIDATION; AMPHIPHILICS; AQUEOUS SOLUTIONS; CARBOXYLIC GROUP; CONCENTRATION OF; DEGREE OF SUBSTITUTION; FREQUENCY INDEPENDENT; FREQUENCY RANGES; GLUCURONIC ACIDS; HEXADECYLAMIDE; HEXADECYLAMINE; HYALURONIC ACIDS; LOW DEGREE; NEW OPTIONS; ORDERS OF MAGNITUDE; PHOSPHATE BUFFER SALINES; RHEOLOGICAL BEHAVIORS; RHEOLOGICAL PROPERTY; SYNOVIAL FLUID; VISCOELASTIC PROPERTIES; VISCOSUPPLEMENTATION; VOLUME RATIO; WEAK GEL;

AMIDES; BODY FLUIDS; CHEMICAL MODIFICATION; DERIVATIVES; ELASTICITY; FLUIDS; GLUCOSE; HYDROXYLATION; ORGANIC ACIDS; VISCOELASTICITY; VISCOSITY;

RHEOLOGY;

AMIDE; HEXADECYLAMIDE; HEXURONIC ACID; HYALURONIC ACID; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG;

AMIDATION; ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; HORSE; MOLECULAR WEIGHT; NONHUMAN; STREPTOCOCCUS EQUI; SYNOVIAL FLUID; VISCOELASTICITY; YOUNG MODULUS;

AMIDES; ANIMALS; HORSES; HYALURONIC ACID; SYNOVIAL FLUID; VISCOSITY;

EID: 75749118307     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32455     Document Type: Article

References (46)

1. Laurent TC, Fraser JRF. Hyaluronan. FASEB J 1992;6:2397-2404.
2. Terbojevich M, Cosani A, Palumbo M, Pregnolato F. Structural properties of hyaluronic acid in moderately concentrated solutions. Carbohydr Res 1986;149:363-377.
3. Gibbs DA, Merrill EW, Smith KA, Balazs EA. Rheology of hyaluronic acid. Biopolymer 1968;6:777-791.
4. Balazs EA, Denlinger JL. Viscosupplementation: A new concept in the treatment of osteoarthritis. J Rheumatol 1993;20 (Supp 39):3-9.
5. Balazs EA. Viscosupplementation for treatment of osteoarthritis: From initial discovery to current status and results. Surg Technol Int 2004;12:278-289.
6. Kirwan JR, Rankin E. Intra-articular therapy in osteoarthritis. Baillieres Clin Rheumatol 1997;11:769-795.
7. Laurent TC, Fraser JR, Laurent UB, Engstrom-Laurent A. Hyaluronan in inflammatory joint disease. Acta Orthop Scand 1995;66(Supp 226):116-120.
8. Altman D. Laboratory finding in osteoarthritis. In: Moskowitz R, Howell D, Goldberg V, Mankin J, editors. Osteoarthritis-Diagnosis and Medical Surgical Management, 2nd ed. Philadelphia: WB Saunders; 1992. p 313-328.
9. Gomez JE, Thurston GB. Comparison of the oscillatory shear viscoelasticity and composition of pathological synovial fluids. Biorheology 1993;30:409-427.
10. Lapcik L Jr, Lapcik L, De Smedt S, Demeester J, Chabrecek P. Hyaluronan: Preparation, structure, properties and applications. Chem Rev 1998;98:2663-2684.
11. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006;19:CD005321; Review.
12. Wright KE, Maurer SG, Di Cesare PE. Viscosupplementation for osteoarthritis. Am J Orthop 2000;29:80-88.
13. Grecomoro G, La Sala F, Francavilla G. Rheologic changes in the synovial fluid of patients with gonarthitis induced by intraarticular infiltration. Int J Tissue React 2001;32:67-71.
14. Bagga H, Burkhardt D, Sambrook P, March L. Long term effects of intrarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 2006;33:946-950.
15. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: A randomized clinical trial.Hyalgan Study Group. J Rheumatol 1998;25:2203-2212.
16. Petrella RJ, DiSilvestro MD, Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 2002;162:292-298.
17. Wu J, Wang X, Keum JK, Zhou H, Gelfer M, Avila-Orta CA, Pan H, Chen W, Chiao SM, Hsiao BS, Chu B. Water soluble complexes of chitosan-g-MPEG and hyaluronic acid. J Biomed Mater Res 2007;80:800-812.
18. Ghosh P, Guidolin D. Potential mechanism of action of intraarticular therapy in osteoarthiritis: Are the effects molecular weight dependent? Semin Arthritis Rheum 2002;2:10-37.
19. Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with Hylan G-20: A 26 week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 1998;20:410-423.
20. Goldberg VM, Couts RD. Pseudoseptic reactions to hylan viscosupplementation: Diagnosis and treatment. Clin Orthop Relat Res 2004;419:130-137.
21. Schiavinato A, Finesso M, Cortivo R, Abatangelo G. Comparison of the effects of hyaluronan and its chemically crosslinked derivative (Hylan G-F 20) in normal rabbit knee joints. Clin Exp Rheumatol 2002;20:445-454.
22. Ottavini RA, Wooley P, Song Z, Markel DC. Inflammatory and immunological responses to hyaluronan preparations. J Bone Joint Surg 2007;89:148-157.
23. Fernandez-Acenero MJ, Zamora E, Borbujo J. Granulomatous foreign body reaction against hyaluronic acid: Report of a case after lip augumentation. Dermatol Surg 2003;30:1225-1226.
24. Micheels P. Human anti-hyaluronic acid antibodies: Is it possible? Dermatol Surg 2001;28:185-191.
25. Bellini D, Topai A. Amides of hyaluronic acid and the derivatives thereof and a process for their preparation. EP Patent 1095064, 1999.
26. Pelletier S, Hubert P, Payan E, Marchal P, Choplin L, Dellacherie E. Amphipilic derivatives of sodium alginate and hyaluronate for cartilage repair: Rheological properties. J Biomed Mater Res 2001;54:102-108.
27. Borzacchiello A, Ambrosio L, Netti PA, Nicolais L. Rheology of biological fluids and their substitute. In: Yaszemski MJ, Trantolo DJ, Lewandroski KU, Hasirci V, Altobelli DE, Wise DL, editors. Tissue Engineering and Novel Drug Delivery Systems. New York: Marcel Dekker; 2004. p 265-280.
28. Krause WE, Bellomo EG, Colby RH. Rheology of sodium hyaluronate under physiological conditions. Biomacromolecules 2001;2:65-69.
29. Ambrosio L, Borzachiello A, Netti PA, Nicolais L. Rheological study on hyaluronic acid and its derivatives solutions. J Macromol Sci A: Pure Appl Chem 1999;A36:991-1000.
30. Oates KMN, Krause WE, Jones RL, Colby RH. Rheopexy of synovial fluid and protein aggregation. J R Soc Interface 2006;3:167-174.
31. Prestwich G. Therapeutic biomaterials from chemically-modified hyaluronan. In: Garg HG, Hales CA, editors. Chemistry and Biology of Hyaluronan. Amsterdam: Elsevier; 2004. p 475-504.
32. Kawaguki Y, Matsukawa K, Istigami Y. The relation between the adsorption behaviour at the interface and the conformational changes in hyaluronates partially modified with various acyl chains. Carbohydr Polym 1995;26:149-154.
33. Gomis A, Miralles A, Schmidt RF, Belmonte C. Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. Arthritis Rheum 2004;50:314-326.
34. Barbucci R, Lamponi S, Borzacchiello A, Ambrosio L, Fini M, Torricelli P, Giardino R. Hyaluronic acid hydrogel in the treatment of osteoarthritis. Biomaterials 2002;23:4503-4513.
35. Balazs EA, Denlinger JL. Sodium hyaluronate and joint function. Equine Vet Sci 1985;5:217-228.
36. Fung YC. Biomechanics: Mechanical Properties of Living Tissue. New York: Springer Verlag; 1993. p 233.
37. Balazs EA, Bland PA, Denlinger JL, Goldman AI, Larsen NE, Leshchiner EA. Matrix engineering. Blood Coagul Fibrinolysis 1991;2:173-178.
38. Mazzucco D, McKinley G, Scott RD, Spector M. Rheology of joint fluid in total knee arthoplasty patients. J Orthop Res 2002;20:1157-1163.
39. Pozo MA, Balazs EA, Belmonte C. Reduction of sensory responses to passive movements of inflamed knee joint by hylan, a hyaluronan derivative. Exp Brain Res 1997;116:3-9.
40. Gomis A, Miralles A, Schmidt RF, Belmonte C. Nociceptive nerve activity in an experimental model of knee joint osteoarthritis of the guinea pig: Effect of intra-articular hyaluronan application. Pain 2007;130:126-136.
41. Yamazaki K, Fukuda K, Matsukawa M, Hara F, Yoshida K, Akagi M, Munakata H, Hamanishi C. Reactive oxygen species depolymerise hyaluronan: Involvement of the hydroxyl radical. Pathophysiology 2003;9:215-220.
42. Lapcik L, Schurz J. Photochemical degradation of hyaluronic acid by singlet oxygen. Colloid Polym Sci 1991;269:633-635.
43. Saari H, Konttinen YT, Friman C, Sorsa T. Differential effects of reactive oxygen species on native synovial fluid and purified human umbilical cord hyaluronate. Inflammation 1993; 17:403-415.
44. Dimock AN, Siciliano PD, McIlwraith CW. Evidence supporting an increase presence of reactive oxygen species in the diseased equine joint. Inflammation 2000;32:439-443.
45. Martin JP, Colina K, Logsdon N. Role of oxygen radicals in the phototoxicity of tetracyclines toward Escherichia coli B. J Bacteriol 1987;169:2516-2522.
46. Prieto JG, Pulido MM, Zapico J, Molina AJ, Gimeno M, Coronel P, Alvarez AI. Comparative study of hyaluronic acid derivatives: Rheological behaviour, mechanical and chemical degradation. Int J Biol Macromol 2005;35:63-69.